Description
Currently under investigation to study the elimination of
biofilm infections on prosthetic knee implants during early intervention
procedures while maintaining the current standard of care.
- Granted
FDA Breakthrough Device Designation for products that may provide more
effective treatment or diagnosis of life-threatening or irreversibly
debilitating diseases or conditions - In
vivo animal and in vitro lab studies
demonstrated up to 99.6% effectiveness in killing biofilms, including drug-resistant
bacteria such as MRSA, E. Coli, etc. - May
help retain the original implant - BioPrax
is easy to use – requires minimal training - Minimally
invasive procedure